HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David A Brown Selected Research

arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamide

1/2020The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats.
1/2016Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.
11/2015Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart.
1/2014Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.
4/2013Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
6/2012Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.
5/2012Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David A Brown Research Topics

Disease

28Neoplasms (Cancer)
01/2020 - 03/2003
19Ischemia
01/2022 - 02/2003
14Reperfusion Injury
01/2022 - 04/2005
9Infarction (Infarctions)
10/2019 - 12/2003
8Myocardial Infarction
11/2017 - 04/2005
8Prostatic Neoplasms (Prostate Cancer)
11/2009 - 08/2003
7Anorexia
12/2019 - 11/2007
6Hypoxia (Hypoxemia)
01/2020 - 07/2007
6Cachexia
12/2019 - 10/2011
5Wounds and Injuries (Trauma)
01/2022 - 05/2016
5Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 11/2010
5Inflammation (Inflammations)
01/2019 - 10/2011
5Heart Failure
12/2018 - 02/2006
5Stroke (Strokes)
10/2013 - 06/2002
4Obesity
01/2018 - 01/2012
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2016 - 11/2011
4Pain (Aches)
12/2011 - 08/2003
3Necrosis
01/2021 - 07/2013
3Multiple Sclerosis
01/2021 - 12/2012
3Demyelinating Diseases (Demyelinating Disease)
01/2020 - 01/2019
3Weight Loss (Weight Reduction)
12/2019 - 11/2007
3Body Weight (Weight, Body)
12/2019 - 01/2012
3Muscular Diseases (Myopathy)
01/2016 - 01/2015
3Neoplasm Metastasis (Metastasis)
01/2012 - 03/2007
3Cardiac Arrhythmias (Arrythmia)
12/2011 - 04/2010
3Melanoma (Melanoma, Malignant)
02/2009 - 12/2003
3Skin Neoplasms (Skin Cancer)
11/2005 - 09/2002
2Immunoglobulin G4-Related Disease
08/2022 - 01/2022
2COVID-19
02/2022 - 01/2021
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 03/2003
2Neuroinflammatory Diseases
01/2019 - 03/2014
2Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2017
2Breast Neoplasms (Breast Cancer)
07/2014 - 09/2002
2Atherosclerosis
11/2012 - 03/2007
2Colorectal Neoplasms (Colorectal Cancer)
02/2012 - 03/2003
2Ventricular Fibrillation
12/2011 - 04/2010
2Infections
03/2010 - 06/2002
2Aneurysm (Aneurysms)
09/2009 - 05/2004
2Hypertrophy
07/2007 - 02/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2006 - 04/2004
2Adenocarcinoma
01/2006 - 04/2004
2Xeroderma Pigmentosum (Kaposi's Disease)
04/2005 - 09/2002
2Carcinoma (Carcinomatosis)
03/2005 - 03/2003
2Hemiplegia (Spastic Hemiplegia)
02/2005 - 05/2004
1Dermatomyositis (Dermatopolymyositis)
02/2022
1Wound Infection (Wound Infections)
01/2022
1Dengue (Dengue Fever)
12/2021

Drug/Important Bio-Agent (IBA)

17CytokinesIBA
01/2020 - 03/2003
17Growth Differentiation Factor 15IBA
12/2019 - 03/2003
13Transforming Growth Factor beta (TGF-beta)IBA
01/2020 - 03/2003
12Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2003
12Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2003
8Adenosine Triphosphate (ATP)IBA
01/2022 - 04/2005
8Peptides (Polypeptides)IBA
01/2020 - 03/2003
7arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA
01/2020 - 05/2012
6Pharmaceutical PreparationsIBA
01/2020 - 11/2010
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2012
5Cardiolipins (Cardiolipin)IBA
01/2020 - 07/2014
5Myelin-Oligodendrocyte GlycoproteinIBA
01/2020 - 11/2011
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2015 - 03/2003
3AntibodiesIBA
01/2021 - 09/2002
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 - 11/2015
3AutoantibodiesIBA
01/2020 - 01/2019
3LipidsIBA
12/2019 - 12/2013
3Monoclonal AntibodiesIBA
12/2019 - 10/2011
3EnzymesIBA
10/2017 - 04/2013
3KATP ChannelsIBA
04/2014 - 06/2006
3Prostate-Specific Antigen (Semenogelase)IBA
11/2009 - 01/2006
2Immunoglobulin G (IgG)IBA
08/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2021 - 04/2004
2BradykininIBA
01/2020 - 05/2010
2Small Interfering RNA (siRNA)IBA
12/2019 - 02/2009
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2018 - 01/2015
2Biological ProductsIBA
12/2017 - 12/2009
2GoldIBA
04/2017 - 01/2017
2CalciumIBA
03/2016 - 05/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2013 - 12/2003
2Opioid Analgesics (Opioids)IBA
09/2012 - 07/2011
2Sulfhydryl Compounds (Thiols)IBA
05/2012 - 12/2011
2DiamideIBA
12/2011 - 04/2010
2Glutathione (Reduced Glutathione)IBA
12/2011 - 04/2010
2PotassiumIBA
11/2010 - 06/2006
2Messenger RNA (mRNA)IBA
12/2009 - 06/2003
2Hormones (Hormone)IBA
10/2009 - 03/2003
2ezogabine (retigabine)IBA
04/2009 - 08/2003
2ElementsIBA
11/2007 - 07/2007
2Carrier Proteins (Binding Protein)IBA
07/2007 - 03/2005
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2006 - 12/2003
1BNT162 VaccineIBA
02/2022
1SteroidsIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1Succinic Acid (Succinate)IBA
01/2022
1anti-GFAP autoantibodiesIBA
12/2021

Therapy/Procedure

18Therapeutics
01/2020 - 08/2003
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2004 - 02/2003
2Resistance Training
12/2011 - 12/2007
2Physical Therapy Modalities (Physical Therapy Technique)
12/2011 - 02/2005
2Prostatectomy (Retropubic Prostatectomy)
04/2006 - 03/2005
2Cardiopulmonary Bypass (Heart-Lung Bypass)
05/2004 - 02/2003
1Operative Time
01/2022